Transfusion-associated graft-versus-host disease (TA-GVHD), a rare complication of blood transfusion, is usually fatal. Patients in certain clinical categories, including bone marrow transplants, solid tumors and acquired T cell defects, are at greater risk of developing TA-GVHD. It can be prevented by the irradiation of cellular blood products prior to transfusion.
RAD-SURE blood irradiation indicators provide positive, visual verification of irradiation. When attached to blood products, RAD-SURE XR 15 Gy, XR 25 Gy, 15 Gy and 25 Gy indicators show whether the blood products have been irradiated or not. Before a blood product and its attached indicator are irradiated, the indicator reads “NOT IRRADIATED.” After the blood product and its attached indicator are irradiated, the word “NOT” in the indicator window is obscured and the indicator reads “IRRADIATED.”
RAD-SURE indicators are U.S. FDA-registered Class I medical devices.